Sees Q4 gross margin up 50-100bps and adjusted EBITDA margin up 50-100bps. Beyond 2026, sees annual organic revenue growth up 4%-6% with “modest uptrend” in gross margins from improved revenue mix. Comments taken from investor presentation slides at the JPMorgan Healthcare Conference yesterday.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN: